TP53 and ductal breast carcinoma in situ: In agreement with the previous results, GSEA showed enrichment of the cholesterol homeostasis pathway in the TP53 mutation group (NES = 1.62, FDR = 0.053) and DCIS (NES = 1.53, FDR = 0.076) (Figure 2H and Figure S3A, Supporting Information).